SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-055717
Filing Date
2023-11-17
Accepted
2023-11-17 16:09:47
Documents
1
Period of Report
2023-11-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7485
  Complete submission text file 0001209191-23-055717.txt   8926
Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Issuer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1305 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address
Valantine Hannah (Reporting) CIK: 0001855608 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38959 | Film No.: 231418737